Ted Tisch, Janice Chen, Lucas Harrington, Trevor Martin and Peter Nell. (Mammoth)

January 30, 2020 12:21 PM ESTUpdated January 30, 08:48 PM

Doudna-founded CRISPR upstart bags $45M for new Cas research, extends its reach into therapeutics

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

view job offer post your job now

TRENDING NOW

Updated: To spin off or not to spin off? Galapagos backpedals on separation plans, CEO Paul Stoffels exits early

Bayer starts 2025 by cutting 2,000 jobs as it homes in on year-end rehaul target

Dutch biotech gets $146M for late-stage trials in three metabolic disorders

TIGIT graveyard expands as GSK drops late-stage asset with iTeos

Arcturus to prioritize mRNA therapeutics in bid to boost rare disease programs

UnitedHealth Group CEO Andrew Witty steps down